Table 3. Targeted and Actual Blood Levels of tacrolimus and sirolimus (ng/ml).
CNI Minimized Group | |||||||
Tacrolimus | Sirolimus | Tacrolimus + Sirolimus | |||||
Months | Target | Actual | Target | Actual | Target | Actual | |
7–12 | 2–4 | 5.0 ± 2.0 | 4–6 | 6.8 ± 1.6 | 8–10 | 11.0 ± 2.4 | |
13–24 | 2–4 | 4.6 ± 2.3 | 4–6 | 6.6 ± 1.7 | 8–10 | 10.5 ± 2.2 | |
CNI Withdrawn Group | |||||||
Tacrolimus | Sirolimus | MMF Dose (g, PO, QD) | |||||
Months | Target | Actual | Target | Actual | Actual | ||
7–12 | N/A | N/A | 8–12 | 10.5 ± 1.2 | 1.9 ± 0.3 | ||
13–24 | N/A | N/A | 8–12 | 10.4 ± 1.4 | 1.9 ± 0.3 |